Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 7, 2005
Synthesis of potent and selective serotonin 5-HT1B receptor ligandsYiyun Huang, Sung-A Bae, Bryan L Roth, et al.
Nuclear Medicine and Biology|February 15, 2011
In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissueNicola Hendry, Isabel Christie, Eugenii Alfredovich Rabiner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2003
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohortAnissa Abi-Dargham, Lawrence S Kegeles, Diana Martinez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 10, 2009
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visitedVincent J Cunningham, Eugenii A Rabiner, Mark Slifstein, et al.
Clinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Journal of Medicinal Chemistry|April 2, 2005
Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agentsYiyun Huang, Sung-A Bae, Zhihong Zhu, et al.
Nuclear Medicine and Biology|June 29, 2002
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonistYolanda Zea-Ponce, Lawrence S Kegeles, Ningning Guo, et al.
Synapse (New York, N.Y.)|August 10, 2004
Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studiesMark Slifstein, Raj Narendran, Dah-Ren Hwang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2003
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophreniaNingning Guo, Dah-Ren Hwang, Ee-Sing Lo, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|September 7, 2005
Synthesis of potent and selective serotonin 5-HT1B receptor ligandsYiyun Huang, Sung-A Bae, Bryan L Roth, et al.
Nuclear Medicine and Biology|February 15, 2011
In vitro assessment of the agonist properties of the novel 5-HT1A receptor ligand, CUMI-101 (MMP), in rat brain tissueNicola Hendry, Isabel Christie, Eugenii Alfredovich Rabiner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2003
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohortAnissa Abi-Dargham, Lawrence S Kegeles, Diana Martinez, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 10, 2009
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visitedVincent J Cunningham, Eugenii A Rabiner, Mark Slifstein, et al.
Clinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Journal of Medicinal Chemistry|April 2, 2005
Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agentsYiyun Huang, Sung-A Bae, Zhihong Zhu, et al.
Nuclear Medicine and Biology|June 29, 2002
Pharmacokinetics and brain distribution in non human primate of R(-)[123I]DOI, A 5HT(2A/2C) serotonin agonistYolanda Zea-Ponce, Lawrence S Kegeles, Ningning Guo, et al.
Synapse (New York, N.Y.)|August 10, 2004
Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studiesMark Slifstein, Raj Narendran, Dah-Ren Hwang, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2003
Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophreniaNingning Guo, Dah-Ren Hwang, Ee-Sing Lo, et al.
Pageof 11